Clinical TrialsSearch results
Number of results: 508
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Japanese Extracranial-Intracranial Arterial Bypass Trial
- Symptomatic internal carotid artery or middle cerebral artery occlusion or stenosis
- JET Study Group
- 2005-09-08
Other
- MCA Embolism Local Fibrinolytic Intervention Trial
- Middle cerebral artery embolism
- MELT Study Group
- 2005-09-08
Other
- phase II study of gefitinib as a first-line therapy in elderly patients with lung adenocarcinoma.
- lung adenocarcinoma
- West Japan Oncology Group
- 2005-09-08
Other
- Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE)
- Untreated essential hypertensive patients
- HOMED-BP Study Group
- 2005-09-09
Other
- Study of imatinib monotherapy and combination of imatinib with IFN or cytarabine ocfosfate for chronic-phase CML (JALSG CML202 Study)
- Previously untreated chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2005-09-10
Other
- Randomized Controlled Trial for the Prevention of Intraventricular Hemorrhage by Indomethacin in Japanese Extremely Low Birth Weight Infants.
- Extremely Low Birth Weight Infants (Intraventricular Hemorrhage , Patent ductus arteriosus)
- Neonatal Research Network Japan
- 2005-09-11
Other
- Phase I study of S-1 with concurrent thoracic radiation therapy for elderly inoperable locally advanced non-small-cell lung cancer
- Elderly inoperable locally advanced non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase I/II study of cisplatin and S-1 with concurrent thoracic radiation therapy for inoperable locally advanced non-small-cell lung cancer (OLCSG 0501)
- inoperable locally advanced non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II study of irinotecan and amrubicin for relapsed non-small-cell lung cancer
- Relapsed non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II study of topotecan and amrubicin for metastatic or relapsed small-cell lung cancer
- Metastatic or relapsed small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12